CD28-CAR-T cell activation through FYN kinase signaling rather than LCK enhances therapeutic performance

CD28-CAR-T细胞通过FYN激酶信号通路而非LCK信号通路激活,可增强治疗效果。

阅读:1
作者:Ling Wu ,Joanna Brzostek ,Previtha Dawn Sakthi Vale ,Qianru Wei ,Clara K T Koh ,June Xu Hui Ong ,Liang-Zhe Wu ,Jia Chi Tan ,Yen Leong Chua ,Jiawei Yap ,Yuan Song ,Vivian Jia Yi Tan ,Triscilla Y Y Tan ,Junyun Lai ,Paul A MacAry ,Nicholas R J Gascoigne

Abstract

Signal transduction induced by chimeric antigen receptors (CARs) is generally believed to rely on the activity of the SRC family kinase (SFK) LCK, as is the case with T cell receptor (TCR) signaling. Here, we show that CAR signaling occurs in the absence of LCK. This LCK-independent signaling requires the related SFK FYN and a CD28 intracellular domain within the CAR. LCK-deficient CAR-T cells are strongly signaled through CAR and have better in vivo efficacy with reduced exhaustion phenotype and enhanced induction of memory and proliferation. These distinctions can be attributed to the fact that FYN signaling tends to promote proliferation and survival, whereas LCK signaling promotes strong signaling that tends to lead to exhaustion. This non-canonical signaling of CAR-T cells provides insight into the initiation of both TCR and CAR signaling and has important clinical implications for improvement of CAR function.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。